marketcap
Facebook
Twitter
Telegram
Report an ErrorQuarterly report 2024-Q3
added 11-06-2024
Edwards Lifesciences Corporation Balance Sheet 2011-2024 | EW
Annual Balance Sheet Edwards Lifesciences Corporation
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Debt |
-522 M | -147 M | -242 M | -561 M | -247 M | 122 M | 218 M | 233 M | 388 M | 729 M | 689 M | 88.9 M | 258 M |
Long Term Debt |
597 M | 596 M | 596 M | 595 M | 594 M | 594 M | 438 M | 822 M | 600 M | 598 M | 593 M | 189 M | 150 M |
Long Term Debt Current |
24.9 M | 25.5 M | 25.5 M | 27.2 M | 25.5 M | - | 598 M | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | 1.44 B | 1.31 B | 1.34 B | 1.36 B | 1.08 B | 898 M | 820 M | 395 M | 307 M |
Total Current Liabilities |
1.2 B | 1.02 B | 1.03 B | 894 M | 902 M | 877 M | 1.4 B | 532 M | 476 M | 434 M | 346 M | 347 M | 335 M |
Total Liabilities |
2.64 B | 2.49 B | 2.67 B | 2.66 B | 2.34 B | 2.18 B | 2.74 B | 1.89 B | 1.56 B | 1.33 B | 1.17 B | 742 M | 643 M |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
8.99 B | 7.59 B | 6.07 B | 4.56 B | 3.74 B | 2.69 B | 1.96 B | 3.91 B | 3.34 B | 2.84 B | 2.05 B | 1.65 B | 1.36 B |
Total Assets |
9.36 B | 8.29 B | 8.5 B | 7.24 B | 6.49 B | 5.32 B | 5.7 B | 4.51 B | 4.06 B | 3.52 B | 2.72 B | 2.22 B | 1.98 B |
Cash and Cash Equivalents |
1.14 B | 769 M | 863 M | 1.18 B | 1.18 B | 714 M | 818 M | 930 M | 718 M | 654 M | 420 M | 311 M | 171 M |
Book Value |
6.72 B | 5.81 B | 5.84 B | 4.57 B | 4.15 B | 3.14 B | 2.96 B | 2.62 B | 2.5 B | 2.19 B | 1.56 B | 1.48 B | 1.34 B |
Total Shareholders Equity |
6.65 B | 5.81 B | 5.84 B | 4.57 B | 4.15 B | 3.14 B | 2.96 B | 2.62 B | 2.5 B | 2.19 B | 1.54 B | 1.47 B | 1.34 B |
All numbers in USD currency
Quarterly Balance Sheet Edwards Lifesciences Corporation
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Long Term Debt |
598 M | 597 M | 597 M | 597 M | 597 M | 597 M | 596 M | 596 M | 596 M | - | 596 M | 596 M | 596 M | 595 M | 595 M | 595 M | 595 M | 595 M | 595 M | 594 M | 594 M | 594 M | 594 M | 594 M | 594 M | 594 M | 594 M | 438 M | 438 M | 438 M | 438 M | 822 M | 822 M | 822 M | 822 M | 597 M | 600 M | 600 M | 600 M | 598 M | 598 M | 598 M | 598 M | 593 M | 593 M | 593 M | 593 M | 189 M | - | - | - | - | - | - | - |
Total Non Current Liabilities |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Total Liabilities |
3.36 B | 2.59 B | 2.55 B | 2.64 B | 2.64 B | 2.56 B | 2.59 B | 2.49 B | 2.42 B | - | 2.58 B | 2.67 B | 2.62 B | - | - | 2.66 B | 2.66 B | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Deferred Revenue |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Retained Earnings |
12.8 B | 9.71 B | 9.34 B | 8.99 B | 8.62 B | 8.24 B | 7.93 B | 7.59 B | 7.19 B | - | 6.44 B | 6.07 B | 5.73 B | 5.39 B | 4.9 B | 4.56 B | 4.56 B | 4.56 B | 4.56 B | 3.74 B | 3.74 B | 3.74 B | 3.74 B | 2.69 B | 2.69 B | 2.69 B | 2.69 B | 1.96 B | 1.96 B | 1.96 B | 1.96 B | 3.91 B | 3.91 B | 3.91 B | 3.91 B | 3.34 B | 3.34 B | 3.34 B | 3.34 B | 2.84 B | 2.84 B | 2.84 B | 2.84 B | 2.03 B | 2.03 B | 2.03 B | 2.03 B | 1.65 B | 1.65 B | 1.65 B | 1.65 B | 1.36 B | 1.36 B | 1.36 B | 1.36 B |
Total Assets |
13 B | 10.1 B | 9.74 B | 9.36 B | 9.37 B | 9 B | 8.65 B | 8.29 B | 8.64 B | - | 8.42 B | 8.5 B | 8.16 B | 7.66 B | 7.21 B | 7.24 B | 7.24 B | 7.24 B | 7.24 B | 6.49 B | 6.49 B | 6.49 B | 6.49 B | 5.32 B | 5.32 B | 5.32 B | 5.32 B | 5.67 B | 5.67 B | 5.67 B | 5.65 B | 4.51 B | 4.51 B | 4.51 B | 4.51 B | 4.06 B | 4.06 B | 4.06 B | 4.06 B | 3.52 B | 3.52 B | 3.52 B | 3.52 B | 2.71 B | 2.71 B | 2.71 B | 2.71 B | 2.22 B | 2.22 B | 2.22 B | 2.22 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B |
Cash and Cash Equivalents |
3.68 B | 1.64 B | 1.22 B | 1.13 B | 1.41 B | 1.05 B | 876 M | 769 M | 1.25 B | 1.2 B | 1.04 B | 863 M | 1.52 B | 1.31 B | 1.17 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 1.18 B | 714 M | 714 M | 714 M | 714 M | 818 M | 818 M | 818 M | 818 M | 930 M | 930 M | 930 M | 930 M | 718 M | 718 M | 718 M | 718 M | 654 M | 654 M | 654 M | 654 M | 420 M | 420 M | 420 M | 420 M | 311 M | 311 M | 311 M | 311 M | 171 M | 171 M | 171 M | 171 M |
Book Value |
9.61 B | 7.5 B | 7.19 B | 6.72 B | 6.73 B | 6.45 B | 6.06 B | 5.81 B | 6.22 B | - | 5.84 B | 5.84 B | 5.54 B | 7.66 B | 7.21 B | 4.57 B | 4.57 B | 7.24 B | 7.24 B | 6.49 B | 6.49 B | 6.49 B | 6.49 B | 5.32 B | 5.32 B | 5.32 B | 5.32 B | 5.67 B | 5.67 B | 5.67 B | 5.65 B | 4.51 B | 4.51 B | 4.51 B | 4.51 B | 4.06 B | 4.06 B | 4.06 B | 4.06 B | 3.52 B | 3.52 B | 3.52 B | 3.52 B | 2.71 B | 2.71 B | 2.71 B | 2.71 B | 2.22 B | 2.22 B | 2.22 B | 2.22 B | 1.98 B | 1.98 B | 1.98 B | 1.98 B |
Total Shareholders Equity |
9.55 B | 7.44 B | 7.12 B | 6.65 B | 6.73 B | 6.45 B | 6.06 B | 5.81 B | 6.22 B | 5.94 B | 5.84 B | 5.84 B | 5.54 B | 5.13 B | 4.66 B | 4.57 B | 4.57 B | 4.57 B | 4.57 B | 4.15 B | 4.15 B | 4.15 B | 4.15 B | 3.14 B | 3.14 B | 3.14 B | 3.14 B | 2.96 B | 2.96 B | 2.96 B | 2.96 B | 2.62 B | 2.62 B | 2.62 B | 2.62 B | 2.5 B | 2.5 B | 2.5 B | 2.5 B | 2.19 B | 2.19 B | 2.19 B | 2.19 B | 1.54 B | 1.54 B | 1.54 B | 1.54 B | 1.47 B | 1.48 B | 1.48 B | 1.48 B | 1.33 B | 1.34 B | 1.34 B | 1.34 B |
All numbers in USD currency